Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety, Tolerability, and Efficacy of Topical Diphencyprone for Cutaneous Neurofibromas: Results From a Phase I Clinical Trial.
Journal: The Journal of investigative dermatology
Published: May 19, 2025
Dermatology access for patients with neurofibromatosis type 1 (NF1): a survey study.
Journal: Archives of dermatological research
Published: September 14, 2024
Dermatology images: Frequent cutaneous findings in neurofibromatosis type 1.
Journal: Journal of the American Academy of Dermatology
Published: June 12, 2024
Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1.
Journal: The British journal of dermatology
Published: February 25, 2024
Neurofibromatosis Type 1: Optimizing Management with a Multidisciplinary Approach.
Journal: Journal of multidisciplinary healthcare
Published: December 10, 2023
Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments.
Journal: Cancers
Published: March 29, 2023
Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.
Journal: Brain sciences
Published: April 26, 2022
Showing 1-7 of 7
Last Updated: 09/26/2026